Summary
Speeds up the process of reclassifying marijuana and increases research on the medical benefits of marijuana and CBD products for patients.
What problem does this solve?
Federal rules have treated marijuana as a drug with no medical use, which has stopped important research. This leaves millions of patients and their doctors without good information on how to use it safely for pain and other conditions. This order directs the government to change marijuana's classification and create new rules to support research and protect consumers.
Who does this affect?
- Patients with chronic pain and other medical conditions
- Healthcare providers
- Medical researchers
What does this order do?
Reference
Text:
Section:
Header:
Rescheduling medical marijuana and improving access to cannabidiol products
Speeds up marijuana rescheduling
Orders the Attorney General to take all necessary steps to quickly complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act.
Reference
Text:
Section:
Header:
Rescheduling medical marijuana and improving access to cannabidiol products
Creates a new regulatory plan for CBD products
Directs officials to work with Congress to create rules for hemp-derived CBD products. This includes setting limits on the amount of THC allowed in each serving and container.
Reference
Text:
Section:
Header:
Rescheduling medical marijuana and improving access to cannabidiol products
Promotes research using real-world evidence
Requires health agencies to develop new research methods to study the effects of medical marijuana and CBD. This research will use real-world evidence to better understand health outcomes.
Acknowledges accepted medical uses of marijuana
States that the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) have found credible scientific support for using marijuana to treat pain, anorexia, and nausea.
What is the real world impact?
•
Opens the door for a regulated cannabis market
Directs the government to speed up the rescheduling of marijuana and create a new regulatory framework for CBD. This could pave the way for a large, federally regulated, and taxable market for cannabis products, benefiting both the government and private industry.
•
Closes the gap between public use and scientific knowledge
Recognizes that millions of Americans, including seniors and veterans, already use marijuana and CBD for medical reasons like chronic pain. Aims to increase research to provide patients and doctors with clear guidance on safe and effective use, which is currently lacking.
When does this start?
This order takes effect on December 18, 2025, and directs government agencies to act as quickly as possible.